MD Anderson's Integrative Medicine Program published a Cancer Medicine paper on April 13 showing biofield therapy reduced liver metastases in mouse pancreatic cancer models by more than 50% across three repeated experiments. The four-year study was funded by the Emerald Gate Charitable Trust. It is the first time a tier-one cancer research institution has run biofield therapy through a placebo-ruled-out preclinical protocol with a measurable biological outcome.

The same week produced two peer-reviewed consciousness-theory advances: Tononi's group extended Integrated Information Theory's framework for computing causal grain in systems that include macro units (Neuroscience of Consciousness, April 15), and Hoorn and Ho formalised the observer's internal state as a physical input to classification within entangled quantum systems (Scientific Reports, April 14). Lumenate, a stroboscopic-light meditation app, debuted exclusive 'Love Meditation Mixes' of John Lennon and Yoko Ono material via the Lennon estate for Record Store Day on April 18 — the widest mainstream cultural placement a non-pharmacological altered-states app has reached this year.

On April 18, President Trump signed an executive order directing HHS/ARPA-H to allocate $50M to match state psychedelic research investments, the FDA to issue National Priority Vouchers to Breakthrough-designated psychedelics, and the FDA/DEA to build a Right to Try pathway that includes ibogaine compounds. Compass Pathways and MAPS responded the same day — Compass citing COMP360 Phase 3 data across 1,000+ treatment-resistant depression participants, MAPS committing to publish an open-access Investigator's Brochure for ibogaine this summer. The week's through-line: biological evidence, consciousness theory, and regulatory infrastructure advanced on three independent tracks in the same five days, and each was moved by a different kind of institution.